ArticlePostepy w kardiologii interwencyjnej = Advances in interventional cardiology2026
The relationship between the Fibrosis-4 (FIB-4) index, occurrence of contrast-induced nephropathy, and prognosis after percutaneous coronary intervention in acute coronary syndromes.
Article in Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The Fibrosis-4 (FIB-4) index is used to assess the risk of liver fibrosis but is also a cardiovascular risk factor. Aim: To analyze the impact of FIB-4 on the incidence of contrast-induced nephropathy (CIN) and clinical outcomes in acute coronary syndrome (ACS). Material and methods: A retrospective study included 1465 patients with ACS who underwent coronary angiography or percutaneous coronary intervention (PCI) and were stratified according to FIB-4 levels: < 1.45, 1.45-3.25, and ≥ 3.25. Results: The subgroup with FIB-4 index ≥ 3.25 showed the highest incidence of CIN (4.8% vs. 5.9% vs. 10.0%; Conclusions: The subgroup of patients with a high FIB-4 index is characterized by a higher percentage of CIN, hospitalizations, and deaths from ACS. A high FIB-4 index value is an independent predictor of short- and long-term mortality. The FIB-4 index is an additional risk factor for poor prognosis in patients with ACS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.